BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Niknia S, Kaeidi A, Hajizadeh MR, Mirzaei MR, Khoshdel A, Hajializadeh Z, Fahmidehkar MA, Mahmoodi M. Neuroprotective and antihyperalgesic effects of orexin-A in rats with painful diabetic neuropathy. Neuropeptides 2019;73:34-40. [DOI: 10.1016/j.npep.2018.11.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Szczepanska-sadowska E, Cudnoch-jedrzejewska A, Sadowski B. Differential role of specific cardiovascular neuropeptides in pain regulation: Relevance to cardiovascular diseases. Neuropeptides 2020;81:102046. [DOI: 10.1016/j.npep.2020.102046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Yu MX, Lei B, Song X, Huang YM, Ma XQ, Hao CX, Yang WH, Pan ML. Compound XiongShao Capsule ameliorates streptozotocin-induced diabetic peripheral neuropathy in rats via inhibiting apoptosis, oxidative - nitrosative stress and advanced glycation end products. J Ethnopharmacol 2021;268:113560. [PMID: 33161027 DOI: 10.1016/j.jep.2020.113560] [Reference Citation Analysis]
3 Babaie F, Kourosh-Arami M, Farhadi M. Administration of Orexin-A into the Rat Thalamic Paraventricular Nucleus Enhances the Naloxone Induced Morphine Withdrawal. Drug Res (Stuttg) 2022;72:209-14. [PMID: 35385881 DOI: 10.1055/a-1744-5868] [Reference Citation Analysis]